期刊文献+

腺苷类似物WS090501的镇静、催眠和抗惊厥作用 被引量:5

Sedative,hypnotic and anticonvulsive effects of an adenosine analogue WS090501
原文传递
导出
摘要 腺苷是一种内源性的嘌呤核苷,具有广泛的生理性调节作用。腺苷类似物具有显著的镇静[1]、催眠和抗惊厥作用[2],可以抑制啮齿类动物的自主活动、诱导NREM睡眠(non rapid-eye-movement sleep,非快动眼睡眠)[3]。 This study is to examine the sedative,hypnotic and anticonvulsive effects of an adenosine analogue,WS090501.The spontaneous locomotor activity was recorded by open field equipment,and the EEG of rats was recorded by polyphysiograph.Pentylenetetrazol(PTZ)-induced seizure model was used.The spontaneous locomotor activity was decreased by WS090501 at various doses(0.06,0.13,and 0.25 mg·kg-1),and the decreasing rate was 28.4%,47.1% and 61.2% respectively.Furthermore,the effect of WS090501 on spontaneous locomotor activity of mice can be antagonized by DPCPX,a selective adenosine A1R antagonist,but cannot be antagonized by SCH58261,a selective adenosine A2AR antagonist.The NREM sleep was significantly increased by WS090501(0.05 and 0.2 mg·kg-1),and the increasing rate was 27.6% and 102.8%,respectively,at 6th hour after administration.The REM sleep decreased significantly at the higher dose.PTZ induced serious convulsion in mice.The latency of convulsion was prolonged,and the number of seizure and mortality decreased after administration of WS090501.These results show that WS090501 has potent sedative,hypnotic and anticonvulsive effects,which may be mediated through adenosine A1R.
作者 李伟 张建军
出处 《药学学报》 CAS CSCD 北大核心 2011年第6期742-746,共5页 Acta Pharmaceutica Sinica
基金 国家自然科学基金资助项目(30973512) 国家“重大新药创制”科技重大专项(2009ZX09301-003,2008ZX09401-004)
关键词 腺苷类似物 腺苷A1R 腺苷A2AR NREM睡眠 自主活动 adenosine analogue adenosine A1R adenosine A2AR NREM sleep locomotor activity
  • 相关文献

参考文献1

二级参考文献1

共引文献26

同被引文献44

  • 1王琳,陈以平.人工培育蝉花菌丝对人系膜细胞增殖及细胞外基质合成的影响[J].中医研究,2006,19(10):9-11. 被引量:17
  • 2刘又高,王根锷,厉晓腊,柴一秋,金轶伟.蝉拟青霉孢子粉对小菜蛾的致病性试验[J].昆虫知识,2007,44(2):256-258. 被引量:15
  • 3柴一秋,金轶伟,刘又高,厉晓腊,陈官菊,王根锷.蝉拟青霉杀虫活性成分的分离[J].中国农业科学,2007,40(9):1952-1958. 被引量:6
  • 4WaffordKA,EbertB.Emergingantiinsomniadrugs:tacklingsleeplessnessandthequalityofwaketime[J].NatRevDrugDiscov,2008,7(6):530-40.
  • 5RothT,DrakeC.Evolutionofinsomnia:currentstatusandfuturedirection[J].SleepMed,2004,5(Suppl1):S23-30.
  • 6SunH,KennedyW P,WilbrahamD,etal.Effectsofsuvorexant,anorexinreceptorantagonist,onsleepparametersasmeasuredbypolysomnographyinhealthymen[J].Sleep,2013,36(2):259-67.
  • 7RoehrsT,RothT.Insomniapharmacotherapy[J].Neurotherapeutics,2012,9(4):728-38.
  • 8ShiY,DongJW,TangLN,etal.N(6)(3methoxyl4hydroxybenzyl) adenineribosideinducessedativeandhypnoticeffectsviaGADenzymeactivationinmice[J].PharmacolBiochemBehav,2014,126:146-51.
  • 9TabatabaiSA,RezaeeZavarehE,ReyhanfardH,etal.Evaluationofanxiolytic,sedativehypnoticandamnesiceffectsofnovel2phenoxyphenyl1,3,4oxadizolederivativesusingexperimentalmodels[J].IranJPharmRes,2015,14(Suppl):51-7.
  • 10BredewoldR,SchiavoJK,vanderHartM,etal.DynamicchangesinextracellularreleaseofGABAandglutamateinthelateralseptumduringsocialplaybehaviorinjuvenilerats:implicationsforsexspecificregulationofsocialplaybehavior[J].Neuroscience,2015,307:117-27.

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部